Kintara Therapeutics Inc (3DMA.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
| Previous close | 0.1724 |
| Open | 0.1682 |
| Bid | 0.1688 x N/A |
| Ask | 0.1880 x N/A |
| Day's range | 0.1682 - 0.1682 |
| 52-week range | 0.0700 - 4.6800 |
| Volume | |
| Avg. volume | 6,578 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
Kintara (KTRA) inks a definitive merger agreement with TuHURA for an all-stock transaction. It is expected to close in the third quarter of 2024. The stock surges 63.4%.
- Zacks
Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
Kintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its breast cancer treatment candidate, REM-001. The stock surges 41%.
© 2024 Yahoo. All rights reserved.